KMC Speciality Hospitals (India) Ltd (KMCSHIL) — share price & stock analysis

Market cap

₹1,354 Cr

P/E

37×

ROE

13.9%

vs own 10-yr valuation

37th pctile

Book value / share

₹11.2

EPS (TTM)

₹2.25

10-yr median P/E

43.4×

Revenue (FY25)

₹232 Cr

Profit after tax (FY25)

₹21 Cr

Weinstein stage

Stage 2 (16 weeks)

Data as of

6 March 2026

5 of the 6 things we track are currently moving the right way — nearly everything is pulling in the same direction.

Where the levels actually stand: ROCE 17% — decent; debt moderate (0.54× equity); margins near the top of their band. Momentum says which way things are moving; these say where they are.

Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double.

Earnings moved first — the price is still catching up

Since Mar 2016, earnings per share grew 1,025% while the stock is up 938%. The business has outrun its own share price.pricettm_eps

When profits grow faster than the price, the stock quietly gets cheaper while doing better — the market hasn’t fully caught up.

Today’s P/E of 37× is the middle of its own range against its own 10-year history (37th percentile) — neither a bargain nor a stretch, by its own standards.pe_ratio

Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots; between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (43.4×).

An uptrend that has held for 16 weeks

Every stock cycles through the same four seasons — a flat base (stage 1), an advance (2), a top (3), a decline (4). Right now this one is in Stage 2: advancing, 16 weeks in, confirmed.stage

The price sits above its rising 200-day average (₹75 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200

Beating NIFTY 500 for 17 weeks — relative strength is the market’s live opinion, and right now it is on this stock’s side.rs_mansfield

What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200

A lumpy ride — no clean trend in profits

Over 11 years, sales went from ₹32.0 Cr to ₹232 Cr (about 20% a year), and profit from ₹0.0 Cr to ₹21.0 Cr.revenuenet_profit

Sales jumped 34% last quarter — growth every single quarter for over 2 years

Dec 25 sales were ₹82.0 Cr, up 34% on the same quarter last year.revenue

That makes 9 quarters of growth in a row — this is a trend, not a blip.revenue

Margins are widening — 26% → 30% in a year

Of every ₹100 of sales, the company keeps ₹30.2 as operating profit (a year ago it kept ₹26.1).opm_pct

Zoom out and this is the page's quiet hero: annual operating margin bottomed at 21.9% in FY20 and has been rebuilt to 24.6% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit

The gross margin barely moved (86% → 86%), so the change came from running costs — the business is getting more efficient as it scales.gpm_pctopm_pct

Profit exploded 75% — mostly from selling more

Dec 25 profit after tax was ₹14.0 Cr, up 75% year on year.net_profit

The profits are real — they turn into cash

Over the last 5 profitable years, the business reported ₹115 Cr of profit and collected ₹183 Cr of operating cash — about 159% conversion.operating_cash_flownet_profit

One asterisk on that strength: suppliers are being paid 73 days later than a year ago (80 → 153 days). Cash flattered by stretching payables is real cash — but it is borrowed timing, not extra earning power.payable_days

The cash cycle looks tighter — but it is supplier credit doing the work

One rupee now takes about -105 days to go out the door as materials and come back as collected cash — down from -40 days the year before.cash_conversion_cycle

Look inside the improvement, though: suppliers are being paid 73 days later (80 → 153 days), while inventory actually got heavier (31 → 38 days). Supplier credit is funding the cycle — useful, but not the same thing as customers paying faster.payable_daysinventory_days

The asset base keeps compounding — this company builds

The productive asset base has gone from ₹28.0 Cr (FY14) to ₹248 Cr.fixed_assetscwip

The build is bigger than the cash engine: investing outflows (₹155 Cr) exceeded operating cash (₹128 Cr) over the last 3 years — the difference comes from debt or shareholders.investing_cash_flowoperating_cash_flow

Debt is present but comfortable

For every ₹100 shareholders have put in (and left in), the company has borrowed ₹54 — total borrowings have grown from ₹16.0 Cr to ₹89.0 Cr over the window.borrowings

Every ₹100 kept in the business earns ₹17 — decent, not special

Return on capital employed is 17.0% (a year ago: 22.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct

The owners aren’t moving

Promoters hold 75.0%, essentially unchanged. Foreign funds own 0.0%, domestic funds null%.promoters_pctfiis_pctdiis_pct

The numbers earn a deeper study — and watch the one thing that matters

The numbers lean positive, and the price hasn’t fully caught up with the improvement.

Best thing in the data: free cash flow rising (₹−18.0 Cr → ₹7.0 Cr).operating_cash_flow

Biggest worry: returns on capital falling (22.0% → 17.0%).roce_pct

Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.

Straight answers from the data